Posters

Presenting Author

Eswara Naga Hanuma Kumar Ghali

Presentation Type

Poster

Discipline Track

Biomedical Science

Abstract Type

Research/Clinical

Abstract

Background: Graphene (G) has been established as an exciting prospect for a broad range of applications owing to its remarkable properties. As the molecular structure of G itself is achiral thus introducing chirality in G by simple attachment of a functional group (a chiral ligand) on the G nanosheet may result in more diverse applications. The recent innovations of G chiral nanosystems have been extended to drug delivery. Herein, we have developed a novel and facile synthesis method for producing chiral G for its application in the chirality-dependent microRNA delivery.

Methods: L-graphene and D-graphene were produced in a single step by using chiral L-tyrosine and D-tyrosine as a stabilizing and chiral-inducing agent and applying high-temperature sonication. The chirality of the exfoliated L-graphene and D-graphene was assessed with circular dichroism (CD) spectroscopy and their structural, morphological, and surface evaluations were studied using Raman spectroscopy, transmission electron microscopy (TEM), and X-ray photoelectron spectroscopy (XPS), respectively. In addition, an attempt has been made to explore the cell viability, hemocompatibility, cellular uptake, and internalization pathway, chirality-mediated interaction, and microRNA (hsa-miR-205-5p) transfection with C4-2B prostate cancer cells.

Results: The CD spectra confirmed the chirality present in the exfoliated L(D)-Graphene. Moreover, the Raman spectrum and TEM data confirmed the formation of multi-layer graphene with asymmetric morphology and a large aspect ratio. L-graphene and D-graphene show cellular compatibility. Chiral preferential binding occurring between miR-205 and D-graphene makes them an exciting prospect for gene delivery. D-graphene exhibits superior hemocompatibility compared to commercially available transfection reagent (Lipofectamine). Cellular uptake is clearly shown by internalization of D-graphene into C4-2B prostate cancer cells. miR-205 efficient delivery utilizing D-graphene was confirmed by transfection efficiency and MTT assay.

Conclusions: Our results demonstrated that a direct approach- one-step liquid phase exfoliation-induced chirality in graphene and their selective chirality-mediated microRNA delivery.

Academic/Professional Position

Fellow

Mentor/PI Department

Immunology and Microbiology

Share

COinS
 

One-step simultaneous liquid phase exfoliation-induced chirality in graphene and their chirality-mediated microRNA delivery

Background: Graphene (G) has been established as an exciting prospect for a broad range of applications owing to its remarkable properties. As the molecular structure of G itself is achiral thus introducing chirality in G by simple attachment of a functional group (a chiral ligand) on the G nanosheet may result in more diverse applications. The recent innovations of G chiral nanosystems have been extended to drug delivery. Herein, we have developed a novel and facile synthesis method for producing chiral G for its application in the chirality-dependent microRNA delivery.

Methods: L-graphene and D-graphene were produced in a single step by using chiral L-tyrosine and D-tyrosine as a stabilizing and chiral-inducing agent and applying high-temperature sonication. The chirality of the exfoliated L-graphene and D-graphene was assessed with circular dichroism (CD) spectroscopy and their structural, morphological, and surface evaluations were studied using Raman spectroscopy, transmission electron microscopy (TEM), and X-ray photoelectron spectroscopy (XPS), respectively. In addition, an attempt has been made to explore the cell viability, hemocompatibility, cellular uptake, and internalization pathway, chirality-mediated interaction, and microRNA (hsa-miR-205-5p) transfection with C4-2B prostate cancer cells.

Results: The CD spectra confirmed the chirality present in the exfoliated L(D)-Graphene. Moreover, the Raman spectrum and TEM data confirmed the formation of multi-layer graphene with asymmetric morphology and a large aspect ratio. L-graphene and D-graphene show cellular compatibility. Chiral preferential binding occurring between miR-205 and D-graphene makes them an exciting prospect for gene delivery. D-graphene exhibits superior hemocompatibility compared to commercially available transfection reagent (Lipofectamine). Cellular uptake is clearly shown by internalization of D-graphene into C4-2B prostate cancer cells. miR-205 efficient delivery utilizing D-graphene was confirmed by transfection efficiency and MTT assay.

Conclusions: Our results demonstrated that a direct approach- one-step liquid phase exfoliation-induced chirality in graphene and their selective chirality-mediated microRNA delivery.

blog comments powered by Disqus
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.